• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Cell Stem Cell . Human Lung Stem Cell-Based Alveolospheres Provide Insights into SARS-CoV-2-Mediated Interferon Responses and Pneumocyte Dysfunction

tetano

Editor, Senior Moderator
Cell Stem Cell


. 2020 Oct 21;S1934-5909(20)30499-9.
doi: 10.1016/j.stem.2020.10.005. Online ahead of print.
Human Lung Stem Cell-Based Alveolospheres Provide Insights into SARS-CoV-2-Mediated Interferon Responses and Pneumocyte Dysfunction


Hiroaki Katsura[SUP] 1 [/SUP], Vishwaraj Sontake[SUP] 1 [/SUP], Aleksandra Tata[SUP] 1 [/SUP], Yoshihiko Kobayashi[SUP] 1 [/SUP], Caitlin E Edwards[SUP] 2 [/SUP], Brook E Heaton[SUP] 3 [/SUP], Arvind Konkimalla[SUP] 4 [/SUP], Takanori Asakura[SUP] 5 [/SUP], Yu Mikami[SUP] 5 [/SUP], Ethan J Fritch[SUP] 6 [/SUP], Patty J Lee[SUP] 7 [/SUP], Nicholas S Heaton[SUP] 3 [/SUP], Richard C Boucher[SUP] 5 [/SUP], Scott H Randell[SUP] 8 [/SUP], Ralph S Baric[SUP] 9 [/SUP], Purushothama Rao Tata[SUP] 10 [/SUP]



Affiliations

Abstract

Coronavirus infection causes diffuse alveolar damage leading to acute respiratory distress syndrome. The absence of ex vivo models of human alveolar epithelium is hindering an understanding of coronavirus disease 2019 (COVID-19) pathogenesis. Here, we report a feeder-free, scalable, chemically defined, and modular alveolosphere culture system for the propagation and differentiation of human alveolar type 2 cells/pneumocytes derived from primary lung tissue. Cultured pneumocytes express the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) receptor angiotensin-converting enzyme receptor type-2 (ACE2) and can be infected with virus. Transcriptome and histological analysis of infected alveolospheres mirror features of COVID-19 lungs, including emergence of interferon (IFN)-mediated inflammatory responses, loss of surfactant proteins, and apoptosis. Treatment of alveolospheres with IFNs recapitulates features of virus infection, including cell death. In contrast, alveolospheres pretreated with low-dose IFNs show a reduction in viral replication, suggesting the prophylactic effectiveness of IFNs against SARS-CoV-2. Human stem cell-based alveolospheres, thus, provide novel insights into COVID-19 pathogenesis and can serve as a model for understanding human respiratory diseases.

Keywords: ACE2; ARDS; SARS-CoV-2; cytokine storm; interferons; organoids; pneumocytes; protease; respiratory cells; surfactants.
 
Back
Top Bottom